Abstract
Sentinel Lymph Node Biopsy in the Setting of Conjunctival Melanoma: Report of Two Cases and Literature Review
Highlights
Conjunctival melanoma (CM) is a very rare malignancy, with an incidence of less than one per million cases per year
We believe based the available evidence that sentinel lymph node mapping (SLNM) and SNLB is feasible, accurate, with a low complication rate in patient with CM
Micro-metastasis through the lymphatic system can only be detected with sentinel lymph node mapping (SLNM) and sentinel lymph node biopsy (SLNB) [6]
Summary
Conjunctival melanoma (CM) is a rare malignancy with an incidence of 0.15 to 0.49 cases per million persons per year [1,2]. We identified two pigmented lesions, one of approximately 1 cm in size and another of approximately 2 cm in size Both lesions had irregular borders, one was in the temporal region, and the other on the nasal region of the eye (Figure 1). The ophthalmology-oncology team performed the resection and the head and neck team, performed the SLNM and SLNB which included a superficial parotidectomy with identification and preservation of the facial nerve (Figure 2). Performed the excision and the head and neck team performed the SLNM and SLNB which included a superficial parotidectomy with identification and preservation of the facial nerve (Figure 4). The final pathology report showed a complete resection with negative margins and the SLNB was negative She is free of disease without evidence of recurrence
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.